ChemoCentryx, Inc. (CCXI): Price and Financial Metrics
ChemoCentryx, Inc. (CCXI)
Today's Latest Price: $58.14 USD
2.44 (-4.03%)
Updated Jun 4 1:06pm
Add CCXI to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CCXI Stock Summary
- With a price/sales ratio of 110.83, ChemoCentryx Inc has a higher such ratio than 97.71% of stocks in our set.
- As for revenue growth, note that CCXI's revenue has grown -18.84% over the past 12 months; that beats the revenue growth of just 10.55% of US companies in our set.
- The volatility of ChemoCentryx Inc's share price is greater than that of 95.99% US stocks with at least 200 days of trading history.
- Stocks that are quantitatively similar to CCXI, based on their financial statements, market capitalization, and price volatility, are PRNB, SYRS, TBIO, MEIP, and RARE.
- Visit CCXI's SEC page to see the company's official filings. To visit the company's web site, go to www.chemocentryx.com.
CCXI Daily Price Range
CCXI 52-Week Price Range
CCXI Stock Price Chart More Charts
CCXI Price/Volume Stats
| Current price | $58.14 | 52-week high | $63.78 |
| Prev. close | $60.58 | 52-week low | $6.16 |
| Day low | $58.02 | Volume | 230,122 |
| Day high | $61.79 | Avg. volume | 646,032 |
| 50-day MA | $51.17 | Dividend yield | N/A |
| 200-day MA | $31.61 | Market Cap | 3.60B |
ChemoCentryx, Inc. (CCXI) Company Bio
ChemoCentryx, Inc. focuses on the discovery, development, and commercialization of orally administered therapeutics to treat autoimmune diseases, inflammatory disorders, and cancer in the United States. The company was founded in 1997 and is based in Mountain View, California.
Loading social stream, please wait...